Needle-free skin immunization using low-frequency ultrasound by Dahlan, A et al.
Needle-free Skin Immunization using Low Frequency Ultrasound 
A. Dahlan, H.O. Alpar and S. Murdan 
Department of Pharmaceutics 
The School of Pharmacy, University of London 
29-39 Brunswick Square, London WC1N 1AX 
Email: afendi.dahlan@pharmacy.ac.uk 
 
Needle-free immunization is desirable due to inherent needle-associated problems and alternative ways of 
vaccination are sought. One technique is the application of low-frequency ultrasound to the skin to 
permeabilize the latter before vaccine application. Indeed low-frequency ultrasound has been shown to assist 
transcutaneous vaccination (Tezel et al, 2005). 
 
In this abstract, we report our study on the influence of the various experimental parameters on the immune 
responses in an attempt to optimize the protocol. In vitro results have shown a marked dependence of the 
extent of antigen permeation on experimental conditions such as ultrasound protocol, nature and volume of 
coupling medium and distance of probe from skin (Dahlan et al, 2005). 
 
Pulses of ultrasound (20 kHz) were applied to the shaved abdominal skin of anesthetized Balb/c mice via a 
coupling medium (20 ml; water or sodium dodecyl sulphate (SDS) solution) for a total sonication time of 45s 
using a probe at 7.5 mm from the skin. After sonication, vaccine (tetanus toxoid) solution was applied to the 
treated skin for 1h. Two booster doses were given on days 15 and 46. Animals were bled on days 14, 45 and 
60 and the serum was analyzed for antibody levels using ELISA. Intramuscular (IM) (±Alum) injections and 
topical applications (±SDS 1%w/v) without US were the controls. The influence of SDS concentration (0, 
0.5 & 1 %w/v) in the coupling medium and of ultrasound duty cycle (0.1s ON, 0.9s OFF vs 0.2s ON, 0.8s 
OFF in every second until total ‘on’ time was 45s) on antibody titres was determined. Statistical tests 
(Kruskal-Wallis test followed by Nemenyi test) were used. 
 
The mean antibody titres (±SD, n=4-5) are shown in Table 1. As expected, the negative controls and the 
positive controls showed low and high immune responses respectively. Ultrasound (US) treatment alone only 
resulted in increased antibody titres after the second boost when it was statistically the same as the IM 
response (p>0.05). Combination of SDS 1%w/v and US resulted in increased immune responses after first 
dose (p<0.05) and antibody levels for all combinations of US and SDS increased with boosting. After the 
first dose, no difference was found between 0.5 and 1 %w/v SDS concentrations (p>0.05). The lower SDS 
concentration has advantage that SDS-associated skin irritancy is expected to be less. 10% duty cycle yielded 
similar immune response as 20% US duty cycle after the first 2 doses, but was surprisingly higher after the 
third dose. 
 
To conclude, we have shown that the extent of the immune response can be modulated by the ultrasound 
experimental parameters.  
 
Table 1 IgG levels of animal groups.  
Numbers represent log serum dilution that gave an OD of 0.2 
are shown. 
Treatment Group Day 14 Day 45 Day 60 
IM injection 3.3±0.9 3.9±0.3 4.5±0 
IM injection + 
Alum 
3.6±0.2 3.9±0.1 5.4±0.3 
Topical application 1.3±0.1 1.2±0 1.3±0.1 
SDS (1%w/v) only 1.2±0 1.2±0 1.2±0 
US(20%) alone 1.4±0.1 1.4±0.4 3.7±0.7 
US(20%) + SDS 
(0.5%w/v) 
1.6±0.3 2.5±0.6 4.8±0.5 
US(20%) + SDS 
(1%w/v) 
2.1±0.2 2.4±0.5 3.7±1.1 
US(10%) + SDS 
(1%w/v) 
2.2±0.7 2.8±0.5 4.2±0.5 
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